Company news
Seer, Inc. (NASDAQ:SEER) news
Every Seer, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.’s Board of Directors
September 4, 2026
Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose...
August 13, 2026
Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference
August 3, 2026
Seer to Report Second Quarter 2026 Financial Results on August 11, 2026
August 3, 2026
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
July 30, 2026
Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting
July 28, 2026
Radoff-JEC Group Urges Seer Stockholders to Vote “FOR” All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY
July 23, 2026
Radoff-JEC Group Urges Seer Stockholders to Vote "FOR" All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY
July 23, 2026
Radoff-JEC Group Announces That Glass Lewis Has Joined ISS in Supporting its Case for Change at Seer, Inc.
July 22, 2026
Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY
July 20, 2026
Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
July 20, 2026
Radoff-JEC Group Announces ISS’ Support of its Case for Change at Seer, Inc.
July 17, 2026
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
July 14, 2026
The Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Company’s Blatant Rewriting of History
July 8, 2026
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
July 8, 2026
The Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.’s Proposal to Acquire Seer, Inc.
July 6, 2026
Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential
July 6, 2026
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
July 2, 2026
The Radoff-JEC Group Releases Presentation Highlighting Why Seer, Inc. Stockholders Should Vote for Boardroom Change
June 29, 2026
The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today
June 24, 2026
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer S...
June 22, 2026
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff an...
June 15, 2026
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
June 3, 2026
Seer Files ITC Complaint Against Nanomics
May 29, 2026
The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stoc...
May 27, 2026
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
May 26, 2026
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
May 21, 2026
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
May 13, 2026
Seer Files Patent Infringement Lawsuit Against Nanomics
May 13, 2026
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer
May 4, 2026
Seer to Report First Quarter 2026 Financial Results on May 13, 2026
April 29, 2026
The Radoff-JEC Group Responds to Seer, Inc.’s Rejection of April 24th Acquisition Proposal
April 29, 2026
Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group
April 27, 2026
The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.
April 24, 2026
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.
April 13, 2026
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
April 9, 2026
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
March 31, 2026
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
March 30, 2026
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets
February 26, 2026
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
February 26, 2026
The Radoff-JEC Group Issues Open Letter to Seer Inc.’s Board of Directors Regarding the Immediate Need for Significant Change
February 23, 2026
Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
February 19, 2026
Seer to Participate in the TD Cowen 46th Annual Health Care Conference
February 18, 2026
Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 5, 2026
Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Bioma...
December 1, 2025
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
November 7, 2025
Seer Reports Third Quarter 2025 Financial Results
November 6, 2025
Seer to Participate in Upcoming November Investor Conferences
October 29, 2025
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
October 16, 2025
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
October 16, 2025